Dr. Sheetal Shroff, MD
NPI: 1619270576
Total Payments
$99,679
2024 Payments
$62,070
Companies
26
Transactions
228
Medicare Patients
1,940
Medicare Billing
$327,866
Payment Breakdown by Category
Other$62,350 (62.6%)
Consulting$23,582 (23.7%)
Travel$8,594 (8.6%)
Food & Beverage$4,863 (4.9%)
Education$291.32 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $62,350 | 29 | 62.6% |
| Consulting Fee | $23,582 | 10 | 23.7% |
| Travel and Lodging | $8,594 | 48 | 8.6% |
| Food and Beverage | $4,863 | 135 | 4.9% |
| Education | $291.32 | 6 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $34,852 | 46 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $33,825 | 44 | $0 (2024) |
| ARGENX US, INC. | $21,373 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $5,071 | 6 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $1,618 | 5 | $0 (2021) |
| UCB SA | $1,186 | 9 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $446.06 | 26 | $0 (2022) |
| Biogen, Inc. | $278.58 | 5 | $0 (2023) |
| Allergan Inc. | $140.32 | 7 | $0 (2018) |
| Akcea Therapeutics, Inc. | $107.73 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $62,070 | 91 | UCB, Inc. ($26,362) |
| 2023 | $20,794 | 49 | Alnylam Pharmaceuticals Inc. ($11,874) |
| 2022 | $10,232 | 17 | Alnylam Pharmaceuticals Inc. ($9,892) |
| 2021 | $1,709 | 12 | Alexion Pharmaceuticals, Inc. ($1,530) |
| 2020 | $2,809 | 7 | Alnylam Pharmaceuticals Inc. ($2,700) |
| 2019 | $1,578 | 26 | UCB SA ($1,186) |
| 2018 | $202.03 | 11 | Allergan Inc. ($72.16) |
| 2017 | $285.66 | 15 | Allergan Inc. ($68.16) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,250.00 | General |
| Category: Neurology | ||||||
| 12/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $1,072.50 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $402.46 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $253.58 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 12/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $80.00 | General |
| Category: Neurology | ||||||
| 12/06/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Consulting Fee | Cash or cash equivalent | $1,611.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/26/2024 | UCB, Inc. | Zilbrysq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,500.00 | General |
| Category: Neurology | ||||||
| 11/26/2024 | UCB, Inc. | Zilbrysq (Drug) | Travel and Lodging | Cash or cash equivalent | $235.84 | General |
| Category: Neurology | ||||||
| 11/26/2024 | UCB, Inc. | Rystiggo (Drug) | Travel and Lodging | Cash or cash equivalent | $75.99 | General |
| Category: Neurology | ||||||
| 11/26/2024 | UCB, Inc. | Rystiggo (Drug) | Travel and Lodging | Cash or cash equivalent | $58.59 | General |
| Category: Neurology | ||||||
| 11/21/2024 | HOSPIRA, INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/21/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Neurology | ||||||
| 11/19/2024 | UCB, Inc. | Zilbrysq (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: Neurology | ||||||
| 11/14/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $101.32 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Neurology | ||||||
| 11/13/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Travel and Lodging | Cash or cash equivalent | $240.50 | General |
| Category: Neurology | ||||||
| 11/12/2024 | UCB, Inc. | Rystiggo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: Neurology | ||||||
| 10/24/2024 | UCB, Inc. | Rystiggo (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Neurology | ||||||
| 10/24/2024 | UCB, Inc. | Rystiggo (Drug) | Travel and Lodging | Cash or cash equivalent | $36.18 | General |
| Category: Neurology | ||||||
| 10/24/2024 | UCB, Inc. | Rystiggo (Drug) | Travel and Lodging | Cash or cash equivalent | $5.49 | General |
| Category: Neurology | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 441 | 664 | $232,356 | $76,605 |
| 2022 | 8 | 433 | 733 | $238,735 | $82,266 |
| 2021 | 10 | 526 | 893 | $273,907 | $91,574 |
| 2020 | 10 | 540 | 862 | $244,702 | $77,421 |
Total Patients
1,940
Total Services
3,152
Medicare Billing
$327,866
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 130 | 172 | $54,352 | $22,658 | 41.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 68 | 186 | $55,800 | $14,381 | 25.8% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 55 | 55 | $49,641 | $11,961 | 24.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 57 | 120 | $28,800 | $11,303 | 39.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 49 | 49 | $17,150 | $6,516 | 38.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 34 | 34 | $15,300 | $5,916 | 38.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 21 | 21 | $6,636 | $2,245 | 33.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 15 | $3,540 | $1,341 | 37.9% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 12 | 12 | $1,137 | $284.76 | 25.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 131 | 172 | $54,352 | $23,575 | 43.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 57 | 175 | $42,000 | $14,158 | 33.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 47 | 124 | $37,200 | $10,387 | 27.9% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 43 | 43 | $39,087 | $9,946 | 25.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 38 | 41 | $14,350 | $6,547 | 45.6% |
| 95937 | Testing of nerve-muscle junction | Office | 2022 | 22 | 57 | $9,576 | $5,098 | 53.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 23 | 23 | $10,350 | $3,998 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 28 | 32 | $10,112 | $3,747 | 37.1% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 12 | 12 | $6,660 | $1,842 | 27.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 17 | 18 | $4,248 | $1,622 | 38.2% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 15 | 36 | $10,800 | $1,347 | 12.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 115 | 165 | $52,140 | $22,142 | 42.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 84 | 246 | $59,040 | $20,105 | 34.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 58 | 149 | $44,700 | $12,214 | 27.3% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 43 | 43 | $38,733 | $10,133 | 26.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 27 | 27 | $12,150 | $4,744 | 39.0% |
About Dr. Sheetal Shroff, MD
Dr. Sheetal Shroff, MD is a Student in an Organized Health Care Education/Training Program healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/15/2010. The National Provider Identifier (NPI) number assigned to this provider is 1619270576.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sheetal Shroff, MD has received a total of $99,679 in payments from pharmaceutical and medical device companies, with $62,070 received in 2024. These payments were reported across 228 transactions from 26 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($62,350).
As a Medicare-enrolled provider, Shroff has provided services to 1,940 Medicare beneficiaries, totaling 3,152 services with total Medicare billing of $327,866. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Neurology, Neuromusculoskeletal Medicine & OMM
- Location Houston, TX
- Active Since 12/15/2010
- Last Updated 01/04/2016
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1619270576
Products in Payments
- Rystiggo (Drug) $18,145
- ONPATTRO (Drug) $17,776
- AMVUTTRA (Drug) $15,866
- VYVGART (Drug) $12,675
- Zilbrysq (Drug) $11,483
- VYVGART HYTRULO (Drug) $8,699
- WAINUA (Drug) $3,460
- NUEDEXTA (Drug) $272.98
- Nuedexta (Drug) $173.08
- BOTOX THERAPEUTIC (Biological) $140.32
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $138.30
- TEGSEDI (Drug) $107.73
- UPLIZNA (Drug) $79.04
- Rebif (Biological) $74.45
- SOLIRIS (Drug) $67.44
- LUMIZYME (Drug) $65.45
- XEOMIN (Biological) $53.67
- RADICAVA (Drug) $48.29
- HYQVIA (Biological) $34.64
- Mavenclad (Biological) $30.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Houston
Sandeep Sahay, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $366,850
Student in an Organized Health Care Education/Training Program $366,850
Diego Marines Copado, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $287,975
Student in an Organized Health Care Education/Training Program $287,975
Dr. Eddie Patton, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $235,342
Student in an Organized Health Care Education/Training Program $235,342
Naveen Pemmaraju, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $198,556
Student in an Organized Health Care Education/Training Program $198,556
Laila Tabatabai, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $194,524
Student in an Organized Health Care Education/Training Program $194,524
Syed Naqvi, M.d./M.b.a, M.D./M.B.A
Student in an Organized Health Care Education/Training Program — Payments: $144,401
Student in an Organized Health Care Education/Training Program $144,401